Medical Equipment

Glucose Biosensors Sector Forecast Shows Robust Momentum, Climbing to $30.88 Billion With 13.2% CAGR

February 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Glucose Biosensors Market?

The glucose biosensors market size has seen rapid expansion in recent years. It is forecast to increase from $16.72 billion in 2025 to $18.83 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.6%. The historical growth can be attributed to the increasing prevalence of diabetes, a rising demand for home-based monitoring solutions, enhancements in biosensor sensitivity, the expansion of point-of-care diagnostics, and growing patient awareness of glucose management.

The glucose biosensors market is projected to experience substantial expansion in the coming years, reaching a valuation of $30.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.2%. This anticipated growth during the forecast period is fueled by several factors, including the wider acceptance of digital tools for diabetes management, a heightened call for non-invasive monitoring methods, the proliferation of personalized healthcare options, increased financial commitment to biosensor research and development, and the growing application of AI-powered glucose analytics. Key developments anticipated during this timeframe involve the greater uptake of continuous glucose monitoring systems, an escalating preference for wearable glucose biosensors, the deeper embedding of mobile health platforms, the advancement of non-invasive glucose monitoring techniques, and an intensified emphasis on the precision of real-time data.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10708&type=smp

What Drivers Are Supporting Technological Adoption In The Glucose Biosensors Market?

The growing incidence of diabetes is anticipated to fuel the expansion of the glucose biosensors market in the future. Diabetes is an incurable condition that arises when the pancreas fails to create enough insulin or when the body fails to adequately utilize the insulin that is produced. Individuals with diabetes use glucose biosensors to track their blood glucose levels, which enables them to monitor these levels regularly at their convenience and assists in adjusting their medication for improved diabetes management. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, elevating the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This figure represents a significant increase compared to 3,065,825 in 2022, underscoring a rise of nearly 20%. Consequently, the increasing prevalence of diabetes is driving the growth of the glucose biosensors market.

Which Segments Are Contributing To The Growth Of The Glucose Biosensors Market?

The glucose biosensors market covered in this report is segmented –

1) By Product Type: Continuous Glucose Monitoring, Self-Monitoring Blood Glucose, Non-Invasive Glucose Monitoring

2) By Technology: Electrochemical Biosensors, Optical Biosensors

3) By End Users: Hospitals, Home Care, Diagnostic Centers and Clinics

Subsegments:

1) By Continuous Glucose Monitoring (CGM): Real-Time CGM Systems, Professional CGM Systems

2) By Self-Monitoring Blood Glucose (SMBG): Glucometers, Test Strips

3) By Non-Invasive Glucose Monitoring: Optical Glucose Sensors, Transdermal Sensors

What Trends Are Driving The Growth Trajectory Of The Glucose Biosensors Market?

Major companies engaged in the glucose biosensor market are directing their efforts toward developing innovative solutions, such as next-generation continuous glucose monitoring (CGM) sensors. These advancements are designed to provide real-time, minute-by-minute glucose readings with optional alerts, thereby improving diabetes management and patient safety. Next-generation continuous glucose monitoring (CGM) sensors are advanced devices that continuously measure glucose levels in the interstitial fluid every few minutes, supplying real-time data, trend alerts, and optional alarms to empower patients and clinicians in managing diabetes more effectively. For example, in August 2025, Abbott Laboratories, a US-based healthcare company, launched its next-generation FreeStyle Libre 2 Plus sensor. This sensor transmits continuous glucose readings every minute directly to a compatible smartphone, eliminating the need for manual scanning. It provides automatic, real-time glucose monitoring, complete with optional customizable alerts for high or low glucose levels. Engineered for ease of use, it offers comfortable wear for up to 15 days, is suitable for children aged 2 and older, and can sync with applications to facilitate data sharing with caregivers and healthcare professionals.

Who Are The Major Companies Operating In The Glucose Biosensors Market?

Major companies operating in the glucose biosensors market are Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Medtronic plc, Senseonics Holdings, GlySens Incorporated, LifeScan Inc., Ascensia Diabetes Care Holdings Inc., Nova Biomedical Corporation, AgaMatrix Inc., Trividia Health, Ypsomed AG, Universal Biosensors Inc., SD Biosensor Inc., Taidoc Technology Corporation, Nipro Corporation, i-SENS Inc., ACON Laboratories Inc., ARKRAY Inc., Menarini Diagnostics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/glucose-biosensors-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Glucose Biosensors Market?

North America was the largest region in the glucose biosensors market in 2025. The regions covered in the glucose biosensors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Glucose Biosensors Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10708&type=smp

Browse Through More Reports Similar to the Global Glucose Biosensors Market 2026, By The Business Research Company

Industrial Glucose Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-glucose-global-market-report

Blood Glucose Meters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Biosensors Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/biosensors-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795